Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Pozycja w akcjach #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Cena akcji
$0.14942078
Ostatnia synchronizacja: 2025-05-15
Kapitalizacja rynkowa
$3.86M
Zmiana (1 dzień)
0.10%
Zmiana (1 rok)
0.00%
Kraj
DE
Handel Medigene AG (MDG1)

Kategoria

Wskaźnik P/S dla Medigene AG (MDG1)
Wskaźnik P/S na dzień August 2026 TTM: 0.33
Według najnowszych raportów finansowych i ceny akcji Medigene AG, obecny wskaźnik P/S (TTM) wynosi 0.33. Na koniec 2022 wynosił 1.58.
Historia wskaźnika P/S dla Medigene AG od 2004 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
2026 (TTM) 0.33 -94.44%
2023 5.86 270.74%
2022 1.58 -76.40%
2021 6.70 -37.67%
2020 10.75 15.55%
2019 9.30 -81.25%
2018 49.61 -30.09%
2017 70.97 -38.41%
2016 115.23 29.31%
2015 89.11 1,204.14%
2014 6.83 -18.93%
2013 8.43 -29.80%
2012 12.01 -23.25%
2011 15.64 -52.41%
2010 32.87 915.33%
2009 3.24 -25.83%
2008 4.36 -43.78%
2007 7.76 51.85%
2006 5.11 -35.56%
2005 7.93 -16.62%
2004 9.52 0.00%
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
10.17 3,018.00%
US
10.13 3,006.19%
NL
- -
CH
- -
KR
4.74 1,354.31%
BE